Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
72.00
-0.68 (-0.94%)
Nov 13, 2026, 4:00 PM EST - Market closed

Monopar Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
48843613453140
Market Cap Growth
-17.99%225.25%2552.79%-83.48%-24.23%-42.34%
Enterprise Value
359293128-31618
Last Close Price
72.0065.3022.001.7011.8516.05

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
3.833.172.440.913.042.13
P/TBV Ratio
3.843.172.440.913.042.13

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.00--0.00-
Net Debt / Equity Ratio
-1.02-1.02-1.09-1.30-1.30-1.07
Quick Ratio
43.4151.3311.464.144.1912.85
Current Ratio
43.5651.3511.484.174.2112.98
Return on Equity (ROE)
-15.34%-14.22%-51.42%-107.19%-72.45%-52.57%
Return on Assets (ROA)
-11.61%-10.39%-29.87%-53.66%-39.03%-30.51%
Return on Capital Employed (ROCE)
-20.00%-12.10%-29.40%-158.00%-104.30%-48.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-3.35%-3.14%-11.62%-166.13%-34.34%-22.52%
Buyback Yield / Dilution
-31.37%-95.53%-37.09%-8.70%-1.97%-13.82%
SEC Filings: 10-K · 10-Q